Kortikale Dysplasie als epileptogener Fokus: Verminderte Bindung von I-Iomazenil bei unauffälliger 99mTc-HMPAO SPECT

P. Bartenstein; C. Lehmenkühler; J. Sciuk; G. Schuierer

doi:10.1055/s-0038-1629615

Nuklearmedizin - NuclearMedicine, Table of Contents

Nuklearmedizin 1992; 31(04): 142-144
DOI: 10.1055/s-0038-1629615

Kasuistik

Schattauer GmbH

Kortikale Dysplasie als epileptogener Fokus: Verminderte Bindung von I-Iomazenil bei unauffälliger ^99mTc-HMPAO SPECT

Cortical Dysplasia as an Epileptogenic Focus: Reduced Binding of ¹²³I-Iomazenil with Normal Uptake in ^99mTc-HMPAO SPECT

P. Bartenstein

¹Aus der Klinik und Poliklinik für Nuklcarmcdizin (Dir.: Prof. Dr. Dr. O. Schober), Westfälischen Wilhelms-Universität Münster, FRG

,

C. Lehmenkühler

²der Klinik und Poliklinik für Neurologie (Dir.: Prof. Dr. G. G. Brune), Westfälischen Wilhelms-Universität Münster, FRG

,

J. Sciuk

¹Aus der Klinik und Poliklinik für Nuklcarmcdizin (Dir.: Prof. Dr. Dr. O. Schober), Westfälischen Wilhelms-Universität Münster, FRG

,

G. Schuierer

³dem Institut für Klinische Radiologie (Dir.: Prof. Dr. P. E. Peters) der Westfälischen Wilhelms-Universität Münster, FRG

› Author Affiliations

Abstract

Zusammenfassung

In kortikalen Arealen, die einem epileptischen Fokus assoziiert sind, korreliert meist eine verminderte Benzodiazepin-Rezeptorbindung, darstellbar mit ¹²³I- Iomazeml, mit einer Minderung des regionalen zerebralen Blutflusses. Anhand eines Fallbeispiels mit ausgeprägter Minderung der ¹²³l-lomazenilbindung im epileptischen Fokus bei ungestörtem regionalen zerebralen Blutfluß wird illustriert und diskutiert, daß bei einer Minderanreicherung von ¹²³I-Iomazenil im epileptischen Fokus eine Alteration des GABAergen Systems anzunehmen ist.

Summary

In cortical areas associated with an epileptic focus, there is, in the majority of cases, a correlation between decreased benzodiazepine (Bz) receptor binding, detectable with ¹²³I-Iomazeml, and decreased blood flow. A patient with focal epilepsy due to a localized abnormality in cortical differentiation is presented who showed a marked focal decrease in Bz receptor binding and a normal ^99mTc-HMPAO SPECT. Based on this case the relation between blood flow and Bz receptor binding in epileptic foci is discussed.

Schlüsselwörter

Kortikale Dysplasie - Epilepsie - SPECT - Benzodiazepinrezeptoren

Key words

Cortical dysplasia - epilepsy - SPECT - benzodiazepine receptors

Full Text

References

Literatur
1 Bangerl I, Riccabona G, Bauer G. et al. ¹²³I-Iomazcnil brain SPECT in various forms of epilepsy (a preliminary report). Eur J Nucl Med 1989; 15: 408.
2 Bartenstein P, Ludolph A, Schober O. et al. Benzodiazepine receptors and cerebral blood flow in partial epilepsy. Eur J Nucl Med 1991; 18: 111-8.
3 Bartenstein P, Schober O. In-vivo-Darstellung von Bcnzodiazcpinrczcptoren des zentralen Typs. Wien Klin Wschr 1991; 103: 647-8.
4 Beer HF, Bläuenstcin PA, Hasler PH. et al. In vitro and in vivo evaluation of Iodine- 123-Ro 16-0154: A new imaging agent for SPECT investigations of benzodiazepine receptors. J Nucl Med 1990; 31: 1007-14.
5 Bicrsack HJ, Linke D, Brassel F. et al. Technetium-99m HM-PAO brain SPECT in epileptic patients before and during unilateral hemispheric anesthesia (Wada test): report of three cases. J Nucl Med 1987; 28: 1763-7.
6 Brune GG. Serotonin metabolism in patients with idiopathic grand mal seizures. J Neurol 1978; 219: 283-7.
7 Chapman AG. Amino acid abnormalities in plasma. CSF and brain in epilepsy. In: Recent advances in epilepsy. Pedley TA, Mcldrum BS. eds. Edinburgh: Churchill Livingstone; 1988: 45-62.
8 Enna SJ. The GABA receptors. Clifton, New Jersey: The Human Press; 1983
9 Holthoff VA, Koeppe RA, Frey KA. et al. Differentiation of radioligand delivery and binding in the brain: validation of a two compartment model for ¹’C-flumazenil. J Cereb Blood Flow Metab 1991; 11 (Suppl. 02) 614.
10 Innis RB, AI-Tikriti MS, Zoghbi SS. et al. SPECT imaging of the benzodiazepine receptor: feasibility of in vivo potency measurements from stepwise displacement curves. J Nucl Med 1991; 32: 1754-61.
11 Podreka I, Suess E, Goldenberg G. et al. Initial experience with Technetium 99m- HMPAO brain SPECT. J Nucl Med 1987; 28: 1657-66.
12 Price JC, Mayberg HS, Dannais RF. et al. Estimation of benzodiazepine receptor binding parameters using ¹¹C-Flumazenil and PET: Equilibrium and kinetic methods. J Cereb Blood Flow Metab 1991; 11 (Suppl. 02) 612.
13 Ribak CE. Axon terminals of GABAergic chandelier cells are lost at epileptic foci. Brain Res 1985; 326: 251-60.
14 Schubiger PA, Hasler PH, Beer-Wohlfahrt H. et al. Evaluation of a multicenter study with lomazenil - a benzodiazepine receptor ligand. Nucl Med Comm 1991; 12: 569-82.
15 Sherwin A, Matthew E, Blain M, Guevremont D. Benzodiazepine receptor binding is not altered in human epileptogenic cortical foci. Neurology 1986; 36: 1380-2.
16 Sherwin A, Robitaille Y, Quesney F. et al. Excitatory amino acids are elevated in human epileptic cerebral cortex. Neurology 1988; 38: 920-3.
17 Verhoeff NPLG, van Royen EA, Ell PJ. et al. Benzodiazepine receptor density in human brain measured in vivo with ¹²³J-Ioma- zenil SPECT. In: Nuclear Medicine: The state of the art of nuclear medicine in Europe. Schmidt HAE, van der Schoot JB. eds. Stuttgart: Schattauer; 1990: 203-6.